Table 4. F. hepatica cathepsin L variants used for the MD simulations.
Subsite | S3 | S2 | S2 | S1′ | S2 | |
Residue | 61 | 67 | 157 | 158 | 205 | |
Structure | Description | |||||
FhCL1 | Asn | Leu | Val | Asn | Leu | Wild-type FhCL1 |
FhCL2 | Tyr | Tyr | Leu | Thr | Leu | FhCL2 S1′, S2, and S3 subsites |
FhCL3 | His | Trp | Val | Thr | Val | FhCL3 S1′, S2, and S3 subsites |
HK | Asp | Tyr | Leu | Asn | Leu | Human cathepsin K |
GZ | His | Trp | Ala | Asn | Phe | Ginger rhizome peptidase |
FhCL1 variants used for the MD simulations and their relationship to the substrate binding subsites of FhCL2 and FhCL3 variants. Substituted residues are in red and papain numbering is used for residue positions. For reference, the equivalent residues in the collagenolytic cathepsins human cathepsin K and ginger rhizome peptidase are also given.